24.12.2012 Views

Oral Abstract Session 01 - Global HIV Vaccine Enterprise

Oral Abstract Session 01 - Global HIV Vaccine Enterprise

Oral Abstract Session 01 - Global HIV Vaccine Enterprise

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Topic 5: <strong>HIV</strong> Transmission and Viral Diversity<br />

P05.03<br />

Low Selection Rate of HLA-Anchor Escape Mutations<br />

in <strong>HIV</strong> After Transmission of Subtype B and<br />

Recombinants BF Strains Patients from Argentina<br />

G. Damilano 1 , E. Socias 2 , C. Magneres 2 , G. Turk 1 , M. Gomez-<br />

Carrillo 1 , H. Salomon 1 , D. Dilernia 1<br />

1 Argentinean Reference Center for AIDS, Buenos Aires,<br />

Argentina; 2 HUESPED Foundation, Buenos Aires, Argentina<br />

Background: The immune response of <strong>HIV</strong>-infected individuals<br />

shapes the evolution of the virus by selecting escape mutation.<br />

After transmission to a new host, the HLA-mediated immune<br />

pressure changes. The objective of our study was to characterize<br />

the dynamics of HLA-anchor escape mutations after transmission.<br />

Methods: We studied 6 transmission events between members<br />

of serodiscordant couples collecting blood samples from the<br />

donor and the previously seronegative-partner at the moment<br />

of seroconversion, and a second sample at least 6 months postinfection.<br />

HLA-I typing was performed by the SSOP-PCR method.<br />

The viral gene gag was amplified by RT-PCR and cloned into the<br />

pGEM-T vector for viral quasiespecies analysis. Transmitted<br />

strain was identified by phylogenetic analysis. Escape mutation<br />

was defined as viral polimorphisms located in HLA-anchor<br />

position that eliminate an epitope predicted by the NetMHC (CBS<br />

Prediction Server). Significant variations in the number of escape<br />

mutations were assessed by Poisson´s probability distribution.<br />

Results: Of the total epitopes available in transmitted gag for<br />

recognition by the recipient HLA alleles, a mean 7.25% of them<br />

selected escape mutations by the moment of the second sample<br />

collection in an anchor position of the epítope. Of the total of HLAanchor<br />

escape mutations present in the second sample and absent<br />

in the subtype consensus, a mean 79,8% were already present in<br />

the first sample of the recipient and in the sample of the donors.<br />

Also, the majority (84%) of the escape mutations to the donor’s<br />

HLA alleles persisted in time after transmission without reversion,<br />

even in the absence of the selecting HLA allele.<br />

Conclusion: The low rate of newly selected escape mutations<br />

could be due in part to lack of immune pressure, but considering<br />

the high rate of transmission and persistence, our results suggest<br />

a high level of viral adaptation to the HLA system in subtype B<br />

and recombinants BF circulating in Argentina.<br />

P05.04<br />

AIDS <strong>Vaccine</strong> 2<strong>01</strong>2<br />

Posters<br />

The Efficiency of Bridging Sheet Recruitment<br />

Determines <strong>HIV</strong>-1 R5 Envelope Sensitivity to Soluble<br />

CD4 and Macrophage Tropism<br />

O. O’Connell 6 , A. Repik 6 , J.D. Reeves 1 , M.P. Gonzalez-Perez 6 ,<br />

B. Quitadamo 6 , M. Duenas-Decamp 6 , P. Peters 6 , R. Lin 2 ,<br />

E.D. Anton 1 , S. Zolla-Pazner 3 , D. Corti 4 , A. Wallace 6 , S. Wang 6 ,<br />

X. Kong 5 , S. Lu 6 , P.R. Clapham 6<br />

1 Monogram Biosciences, San Francisco, CA, USA; 2 University<br />

of Massachusetts, Amherst, MA, USA; 3 New York University<br />

Langone School of Medicine, New York, NY, USA; 4 Humabs<br />

Biomed SA, Bellinzona, Switzerland; 5 New York University<br />

School of Medicine, New York, NY, USA; 6 University of<br />

Massachusetts Medical School, Worcester, MA, USA<br />

Background: <strong>HIV</strong>-1 R5 viruses vary extensively in their capacity<br />

to infect macrophages. R5 viruses that confer efficient infection<br />

of macrophages are able to exploit low levels of CD4 for infection<br />

and they predominate in brain tissue where macrophages are a<br />

major target for infection. <strong>HIV</strong>-1 R5 variants that are transmitted<br />

are generally non-macrophage-tropic. Here, we investigated the<br />

sensitivity of macrophage-tropic and non-macrophage-tropic R5<br />

envelopes to neutralizing antibodies.<br />

Methods: Env+ pseudovirion neutralization assays were carried<br />

out using HeLa TZM-bl cells. Envelope capture ELISAs assessed<br />

monoclonal antibody binding to monomeric gp120.<br />

Results: We observed striking differences in the sensitivity of<br />

Env+ pseudovirions to soluble CD4 compared to neutralizing<br />

monoclonal antibodies that target the CD4 binding site.<br />

Macrophage-tropic R5 envelopes were sensitive to sCD4, while<br />

non-macrophage-tropic envelopes were significantly more<br />

resistant. In contrast, all envelopes were sensitive to VRC<strong>01</strong><br />

regardless of tropism, while mab b12 conferred an intermediate<br />

neutralization pattern with all the macrophage-tropic and about<br />

half of the non-macrophage-tropic envelopes sensitive.<br />

Conclusion: CD4, b12 and VRC<strong>01</strong> share binding specificities on the<br />

outer domain of gp120. However, these reagents differ in their<br />

ability to induce conformational changes on the trimeric envelope<br />

and in specificity for residues on the V1V2 loop stem and β20-21<br />

junction that are targets for CD4 in recruiting the bridging sheet.<br />

These different binding specificities of CD4, b12 and VRC<strong>01</strong> likely<br />

explain the striking differences in envelope sensitivity to inhibition<br />

by these reagents. However, they also provide an insight into the<br />

envelope mechanisms that control macrophage-tropism. We<br />

present a model where the efficiency of bridging sheet recruitment<br />

by CD4 is a major determinant of <strong>HIV</strong>-1 R5 envelope sensitivity to<br />

soluble CD4 and macrophage tropism.<br />

165<br />

POSTERS

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!